A successful year for Bosnalijek, revenue up by 10 percent

Last year was very successful for Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina. In 2018, Bosnalijek had a significant increase of revenue and profit continuing a positive trend from the previous several years.


A successful year for Bosnalijek, revenue up by 10 percent

Bosnalijek's Manager, Nedim Uzunović, pointed out that Bosnalijek's business revenue had increased by 10 percent compared to 2017 where, like in the previous several years, most of the sales revenue, up to 76 percent, had been generated on international markets.              

Positive trend is present in other financial indicators as well, such as EBITDA (earnings before interest, taxes, depreciation and amortization) which was BAM 25.5 million, an increase by 10 percent compared with the previous year.

Profit before tax was BAM 15 million or 14 percent higher compared to 2017.                             

Also, 2018 was marked by significant investments in expanding production capacities and finalization of works on new Quality Control laboratories, which are key prerequisites for future growth and development of Bosnalijek.

Manager Uzunović pointed out that the achieved results represented a strong prerequisite for new investments and new jobs and at the same time contributed to the strengthening of local economy.



March 18, 2019
Previous news
A successful year for Bosnalijek, revenue up by 10 percent Third Generation of American Yale University Students Visits Bosnalijek Notice of convening annual regular assembly of Bosnalijek joint stock co ... Bosnalijek for the 21st Century Postgraduate Students from the American University Yale visit Bosnalije ... Memento – Little Dementia School The First Regional Cardiology Case Report Award Competition (CCRAC 2017 ... Bosnalijek Wins Prestigious Award: Lysobact No. 1 in Sore Throat Remedie ... Together for Clean Waters in Bosnia and Herzegovina Bosnalijek Donates New Equipment to the Spid Swimming Club
april 21. 2019 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%